Cochlear Beheer

Beheer criteriumcontroles 4/4

De CEO Cochlear is Dig Howitt, benoemd in Jul2017, heeft een ambtstermijn van 7.33 jaar. De totale jaarlijkse vergoeding van { bedraagt A$ 6.45M, bestaande uit 32.1% salaris en 67.9% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.094% van de aandelen van het bedrijf, ter waarde $ 12.22M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 7.3 jaar en 4.8 jaar.

Belangrijke informatie

Dig Howitt

Algemeen directeur

AU$6.4m

Totale compensatie

Percentage CEO-salaris	32.1%
Dienstverband CEO	7.3yrs
Eigendom CEO	0.09%
Management gemiddelde ambtstermijn	7.3yrs
Gemiddelde ambtstermijn bestuur	4.8yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Dig Howitt's beloning veranderd ten opzichte van Cochlear's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	AU$6m	AU$2m	AU$357m
Mar 31 2024	n/a	n/a	AU$354m
Dec 31 2023	n/a	n/a	AU$350m
Sep 30 2023	n/a	n/a	AU$326m
Jun 30 2023	AU$6m	AU$2m	AU$301m
Mar 31 2023	n/a	n/a	AU$281m
Dec 31 2022	n/a	n/a	AU$261m
Sep 30 2022	n/a	n/a	AU$275m
Jun 30 2022	AU$5m	AU$2m	AU$289m
Mar 31 2022	n/a	n/a	AU$273m
Dec 31 2021	n/a	n/a	AU$257m
Sep 30 2021	n/a	n/a	AU$291m
Jun 30 2021	AU$5m	AU$2m	AU$324m
Mar 31 2021	n/a	n/a	AU$82m
Dec 31 2020	n/a	n/a	-AU$160m
Sep 30 2020	n/a	n/a	-AU$199m
Jun 30 2020	AU$3m	AU$2m	-AU$238m
Mar 31 2020	n/a	n/a	AU$34m
Dec 31 2019	n/a	n/a	AU$306m
Sep 30 2019	n/a	n/a	AU$291m
Jun 30 2019	AU$4m	AU$2m	AU$277m
Mar 31 2019	n/a	n/a	AU$270m
Dec 31 2018	n/a	n/a	AU$264m
Sep 30 2018	n/a	n/a	AU$255m
Jun 30 2018	AU$3m	AU$2m	AU$246m

Compensatie versus markt: De totale vergoeding ($USD 4.19M ) Dig } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 12.50M ).

Compensatie versus inkomsten: De vergoeding van Dig is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Dig Howitt (57 yo)

7.3yrs

Tenure

AU$6,446,856

Compensatie

Mr. Diggory William Howitt, also known as Dig, BE (Hons), MBA has been President of Cochlear Limited since July 31, 2017 and its Chief Executive Officer and Managing Director since January 3, 2018. Mr. How...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Diggory Howitt	CEO, MD	7.3yrs	AU$6.45m	0.094% $ 12.2m
Stuart Sayers	Chief Financial Officer	8.5yrs	AU$2.46m	0.0052% $ 677.6k
Jan Janssen	Chief Technology Officer	7yrs	AU$2.66m	0.0093% $ 1.2m
Karen O'Driscoll	Chief Information Officer	1.8yrs	geen gegevens	geen gegevens
Kristina Devon	Vice President of Investor Relations	no data	geen gegevens	geen gegevens
Rob McGrory	Group General Counsel & Company Secretary	1.2yrs	geen gegevens	geen gegevens
Jennifer Stevenson	VP of Corporate Communications & Brand	no data	geen gegevens	geen gegevens
Dean Phizacklea	Senior Vice President of Global Strategic Marketing	8.4yrs	geen gegevens	geen gegevens
Jennifer Hornery	Senior Vice President of Global People & Culture	7.8yrs	geen gegevens	geen gegevens
Greg Bodkin	Senior Vice President of Global Supply Chain	no data	geen gegevens	geen gegevens
Anthony Bishop	President of Asia Pacific & Latin America	no data	AU$1.45m	geen gegevens
Kimberley Simpson	Head of Group Tax	no data	geen gegevens	geen gegevens

7.3yrs

Gemiddelde duur

Ervaren management: Het managementteam van CHEO.Y is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7.3 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Diggory Howitt	CEO, MD	7yrs	AU$6.45m	0.094% $ 12.2m
Michael Daniell	Independent Non-Executive Director	4.8yrs	AU$295.72k	0.0025% $ 321.2k
Catriona Deans	Independent Non-Executive Chairman of the Board	9.8yrs	AU$596.78k	0.0069% $ 894.8k
Bruce Robinson	Independent Non-Executive Director	7.9yrs	AU$269.01k	0.0018% $ 235.4k
Karen Lee Penrose	Non-Executive Independent Director	2.3yrs	AU$305.87k	0.0022% $ 282.2k
Glen Boreham	Independent Non-Executive Director	9.8yrs	AU$293.36k	0.0046% $ 599.6k
Michael J. Del Prado	Independent Non-Executive Director	2.8yrs	AU$314.99k	0.0014% $ 187.3k
Christine McLoughlin	Independent Non-Executive Director	4yrs	AU$287.65k	0.0037% $ 477.3k
Caroline Clarke	Non-Executive Director	less than a year	geen gegevens	geen gegevens

4.8yrs

Gemiddelde duur

61yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van CHEO.Y wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.8 jaar).

Cochlear Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Stu Sayers to Appoint as President, Asia Pacific & Latin America of Cochlear Limited, Effective from 1 January 2025

Cochlear Limited Appoints Caroline Clarke as Non-Executive Director, Effective from 2 September 2024

Cochlear Limited Announces Executive Changes

Cochlear Limited Announces Company Secretary Changes

Cochlear Limited Announces Andrew Denver, Non-Executive Director Intention to Retire At AGM to Be Held on 17 October 2023

Cochlear Limited, Annual General Meeting, Oct 17, 2023

Recent updates

Stu Sayers to Appoint as President, Asia Pacific & Latin America of Cochlear Limited, Effective from 1 January 2025

Cochlear Limited Announces Ordinary Dividend for the Period of Six Months Ended June 30, 2024, Payable on October 10, 2024

Cochlear Limited (ASX:COH) announces an Equity Buyback for AUD 75 million worth of its shares.

Cochlear Limited Appoints Caroline Clarke as Non-Executive Director, Effective from 2 September 2024

Cochlear Limited Announces Executive Changes

Cochlear Limited (ASX:COH) acquired Oticon Medical A/s from Demant A/S (CPSE:DEMANT).

Cochlear Limited Announces Company Secretary Changes

Cochlear Limited Receives Fda Clearance to Lower the Age for the Osia System to 5-Year-Old

Cochlear Limited Introduces Next Generation Cochlear Osia System with Ability to Have MRI at 3.0 T

Cochlear Limited to Report Fiscal Year 2024 Results on Aug 15, 2024

Cochlear Limited Announces Andrew Denver, Non-Executive Director Intention to Retire At AGM to Be Held on 17 October 2023

Cochlear Limited Provides Earnings Outlook for the Year 2023

Cochlear Limited (ASX:COH) announces an Equity Buyback for AUD 75 million worth of its shares.

Cochlear Limited, Annual General Meeting, Oct 17, 2023

FDA Approves Cochlear Limited's Nucleus 8 Sound Processor, Smaller, Smarter, Better Connected Cochlear Implant Technology

Cochlear Announces Final Dividend Payable on 17 October 2022

Cochlear Limited Appoints Karen Penrose to Board, Effective on 1 July 2022

Cochlear Limited, Annual General Meeting, Oct 18, 2022

Cochlear Limited to Report First Half, 2023 Results on Feb 15, 2023

Cochlear Limited Announces Interim Dividend Expected to Be Payable on 21 April 2022

FDA Approves Cochlear Nucleus Implants for Unilateral Hearing Loss/Single-Sided Deafness

Cochlear Limited Advises of US Patent Infringement Complaint

Sensorion and Cochlear to Begin First Clinical Trial of SENS-401 for Hearing Preservation in Combination with Cochlear Implantation

Cochlear Limited Provides Earnings Guidance for the Fiscal Year 2022

New Cochlear CoPilot app to help adults improve hearing outcomes through skills training

Cochlear Receives FDA Clearance of Baha 6 Max, Industry's Smallest 55 dB Sound Processor Now with Direct Android Streaming

Cochlear Limited Receives US Food and Drug Administration Approval for Baha 6 Max Sound Processor

Cochlear Limited Appoints Stu Sayers as Chief Financial Officer

Cochlear Limited Appoints Stu Sayers as Acting CFO

Cochlear Limited Appoints Stephen Mayne as Director

Cochlear Limited to Report Fiscal Year 2021 Results on Aug 20, 2021

Cochlear Limited to Report Fiscal Year 2020 Results on Aug 18, 2020

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd